Scarica l'app Stockscreener
1.36
0.73%
-0.01
Dopo l'orario di chiusura:
1.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Opko Health Inc Borsa (OPK) Ultime notizie
Nuveen Asset Management LLC Purchases 425,484 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Two Sigma Investments LP - MarketBeat
Peptide Therapeutics Market Growth Set to Surge Significantly - openPR.com
Quote - OPKO Health, Inc.
Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN
Bone Cancer Drugs Market in 2025-2032 Detailed Study Analysis - openPR.com
BNP Paribas Financial Markets Sells 195,118 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
OPKO Health, Inc. (NASDAQ:OPK) Position Lessened by BNP Paribas Financial Markets - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 8,064 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Q2 EPS Estimates for OPKO Health Reduced by Zacks Research - MarketBeat
Millennium Management LLC Acquires 2,112,382 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Deutsche Bank AG Grows Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Opko Health grants stock options, approves bonuses By Investing.com - Investing.com India
Opko Health grants stock options, approves bonuses - Investing.com
Opko Health Grants Stock Options and Bonuses - TipRanks
Global Smart Inhalers Market to Observe Impressive Growth at a CAGR of ~21% by 2032 | DelveInsight - GlobeNewswire Inc.
OPKO Health (OPK) Rises with Promising Oncology Developments - GuruFocus
Millennium Management LLC Boosts Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Down Syndrome Market: Epidemiology, Therapies, Companies, - openPR.com
What OPKO Health, Inc.'s (NASDAQ:OPK) P/S Is Not Telling You - simplywall.st
Hyperparathyroidism Treatment Market: Effective Treatment - openPR.com
OPKO Health, Inc. (NASDAQ:OPK) Shares Acquired by Lazard Asset Management LLC - MarketBeat
Opko Completes Prolor Deal - Medical Product Outsourcing
Mercer Global Advisors Inc. ADV Grows Stake in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Tower Research Capital LLC TRC Sells 141,878 Shares of OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Esoteric Testing Market Set to Witness Significant Growth - openPR.com
OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Dimensional Fund Advisors LP Lowers Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Price T Rowe Associates Inc. MD Increases Stock Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Raymond James Financial Inc. Takes Position in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Renaissance Technologies LLC Sells 312,950 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times
Clinical Laboratory Tests Market Top PlayersARUP - openPR.com
Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com
0.40%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):